AAAAAA

   
Results: 1-12 |
Results: 12
MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS
Authors: SIMON JH JACOBS LD CAMPION M WENDE K SIMONIAN N COOKFAIR DL RUDICK RA HERNDON RM RICHERT JR SALAZAR AM ALAM JJ FISCHER JS GOODKIN DE GRANGER CV LAJAUNIE M MARTENSDAVIDSON AL MEYER MJ SHEEDER J CHOI K SCHERZINGER AL BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEINSTOCKGUTTMAN B WHITHAM RH
Citation: Jh. Simon et al., MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 43(1), 1998, pp. 79-87
INCIDENCE AND SIGNIFICANCE OF NEUTRALIZING ANTIBODIES TO INTERFERON BETA-1A IN MULTIPLE-SCLEROSIS
Authors: RUDICK RA SIMONIAN NA ALAM JA CAMPION M SCARAMUCCI JO JONES W COATS ME GOODKIN DE WEINSTOCKGUTTMAN B HERNDON RM MASS MK RICHERT JR SALAZAR AM MUNSCHAUER FE COOKFAIR DL SIMON JH JACOBS LD
Citation: Ra. Rudick et al., INCIDENCE AND SIGNIFICANCE OF NEUTRALIZING ANTIBODIES TO INTERFERON BETA-1A IN MULTIPLE-SCLEROSIS, Neurology, 50(5), 1998, pp. 1266-1272
RATIONALE FOR EARLY TREATMENT WITH INTERFERON BETA-1A IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: MUNSCHAUER FE STUART WH
Citation: Fe. Munschauer et Wh. Stuart, RATIONALE FOR EARLY TREATMENT WITH INTERFERON BETA-1A IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Clinical therapeutics, 19(5), 1997, pp. 868-882
MANAGING SIDE-EFFECTS OF INTERFERON-BETA IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS
Authors: MUNSCHAUER FE KINKEL RP
Citation: Fe. Munschauer et Rp. Kinkel, MANAGING SIDE-EFFECTS OF INTERFERON-BETA IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Clinical therapeutics, 19(5), 1997, pp. 883-893
THROMBOEMBOLISM PROPHYLAXIS IN CHRONIC ATRIAL-FIBRILLATION - PRACTICEPATTERNS IN COMMUNITY AND TERTIARY-CARE HOSPITALS
Authors: MUNSCHAUER FE PRIORE RL HENS M CASTILONE A
Citation: Fe. Munschauer et al., THROMBOEMBOLISM PROPHYLAXIS IN CHRONIC ATRIAL-FIBRILLATION - PRACTICEPATTERNS IN COMMUNITY AND TERTIARY-CARE HOSPITALS, Stroke, 28(1), 1997, pp. 72-76
PRIMARY STROKE PREVENTION MODEL - COST-EFFECTIVE ANALYSIS OF INTERVENTIONS
Authors: MUNSCHAUER FE MALIN BT
Citation: Fe. Munschauer et Bt. Malin, PRIMARY STROKE PREVENTION MODEL - COST-EFFECTIVE ANALYSIS OF INTERVENTIONS, Stroke, 28(1), 1997, pp. 199-199
IMPACT OF INTERFERON BETA-1A ON NEUROLOGIC DISABILITY IN RELAPSING MULTIPLE-SCLEROSIS
Authors: RUDICK RA GOODKIN DE JACOBS LD COOKFAIR DL HERNDON RM RICHERT JR SALAZAR AM FISCHER JS GRANGER CV SIMON JH ALAM JJ SIMONIAN NA CAMPION MK BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEISTOCKGUTTMAN B WHITHAM RH
Citation: Ra. Rudick et al., IMPACT OF INTERFERON BETA-1A ON NEUROLOGIC DISABILITY IN RELAPSING MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 358-363
INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS
Authors: JACOBS LD COOKFAIR DL RUDICK RA HERNDON RM RICHERT JR SALAZAR AM FISCHER JS GOODKIN DE GRANGER CV SIMON JH ALAM JJ BARTOSZAK DM BOURDETTE DN BRAIMAN J BROWNSCHEIDLE CM COATS ME COHAN SL DOUGHERTY DS KINKEL RP MASS MK MUNSCHAUER FE PRIORE RL PULLICINO PM SCHEROKMAN BJ WEINSTOCKGUTTMAN B WHITMAN RH BAIRD WC FILLMORE M BONA LM COLONRUIZ ME NADINE BS DONOVAN A BENNETT S KIEFFER YM UMHAUER MA MILLER CE KILIC AK SARGENT EL SCHACHTER M SHUCARD DW WEIDER V CATALANO BA CERVI JM CZEKAY C FARRELL JL FILIPPINI JS MATYAS RC MICHIENZI KE ITO M OMALLEY JA ZIELEZNY MA BRUN JM DAVIDSON AL GREEN LA OREILLY KM SHELTON JA WENDE KE BARILLA DY BOYLE SL PERKINS KK PERRYMAN JE STIEBELING BG KONECSNI JF ROSS JS CHOI KS GUSTAFSON CJ QUANDT BJ SCHERZINGER AL GRIFFITH DA HARRIS JM LEZAK MD MIMICA I SAUNDERS JA COIT WE FORCE CR GILMORE FJ HARRIS LB JONES MM KAUFFMAN JA MARBERGER KE MCBRIDE JW MILLER LL WRIGHT GK BROOKS JA BROWN HR GRAVES ME SCHMIDT JA MOTHENA JW GRAFMAN JH KENWORTHY MK MORTON MM BROWN DM BROWN DC LEVY LM BORDEN EC RANSOHOFF RM VILCEK JT MCCARTHYKIRBY K CAMPION M
Citation: Ld. Jacobs et al., INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 39(3), 1996, pp. 285-294
EMBOLI PROPHYLAXIS IN CHRONIC ATRIAL-FIBRILLATION - PRACTICE PATTERNSIN COMMUNITY AND TERTIARY CARE HOSPITALS
Authors: MUNSCHAUER FE PRIOR RL HENS MM CASTILONE A LENEY G
Citation: Fe. Munschauer et al., EMBOLI PROPHYLAXIS IN CHRONIC ATRIAL-FIBRILLATION - PRACTICE PATTERNSIN COMMUNITY AND TERTIARY CARE HOSPITALS, Circulation, 94(8), 1996, pp. 2092-2092
CIRCULATING NATURAL-KILLER-CELLS BUT NOT CYTOTOXIC T-LYMPHOCYTES ARE REDUCED IN PATIENTS WITH ACTIVE RELAPSING MULTIPLE-SCLEROSIS AND LITTLE CLINICAL DISABILITY AS COMPARED TO CONTROLS
Authors: MUNSCHAUER FE HARTRICH LA STEWART CC JACOBS L
Citation: Fe. Munschauer et al., CIRCULATING NATURAL-KILLER-CELLS BUT NOT CYTOTOXIC T-LYMPHOCYTES ARE REDUCED IN PATIENTS WITH ACTIVE RELAPSING MULTIPLE-SCLEROSIS AND LITTLE CLINICAL DISABILITY AS COMPARED TO CONTROLS, Journal of neuroimmunology, 62(2), 1995, pp. 177-181
TNF DISEASE SUSCEPTIBILITY GENE ANALYSIS IN FAMILIAL MS REVEALS A NOVEL COMPOUND TETRANUCLEOTIDE, DINUCLEOTIDE MICROSATELLITE POLYMORPHISM
Authors: GREENBERG SJ FUJIHARA K SELKIRK SM DU TL YU F RICKERT MH MILLER CE BROWNSCHEIDLE CM MUNSCHAUER FE JACOBS LD
Citation: Sj. Greenberg et al., TNF DISEASE SUSCEPTIBILITY GENE ANALYSIS IN FAMILIAL MS REVEALS A NOVEL COMPOUND TETRANUCLEOTIDE, DINUCLEOTIDE MICROSATELLITE POLYMORPHISM, Neurology, 45(4), 1995, pp. 164-164
PONTOMESENCEPHALIC MAGNETIC-RESONANCE HYPERINTENSITIES
Authors: PULLICINO PM SYNDER WI MILLER LL MUNSCHAUER FE OSTROW PT
Citation: Pm. Pullicino et al., PONTOMESENCEPHALIC MAGNETIC-RESONANCE HYPERINTENSITIES, Annals of neurology, 34(2), 1993, pp. 254-254
Risultati: 1-12 |